Method for recovering protein from surimi-rinsing liquid based on low-temperature plasma technology
US-2025084133-A1 · Mar 13, 2025 · US
US10455849B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10455849-B2 |
| Application number | US-201615140925-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 28, 2016 |
| Priority date | Apr 30, 2015 |
| Publication date | Oct 29, 2019 |
| Grant date | Oct 29, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a method for the preparation of a protein peptide, peptide powder prepared thereby, and use of the peptide powder in hypouricemic food products or health care products. The peptide powder is capable of inhibiting the activity of xanthine oxidase and effectively reducing uric acid. The method in an example of the present invention comprises: mincing the tuna, heating with steam or water to obtain a pretreated tuna, enzymolyzing the pretreated tuna, deactivating the enzyme, centrifuging, removing impurities to obtain a supernatant, concentrating, and drying to obtain the peptide powder of interest.
Opening claim text (preview).
The invention claimed is: 1. A method for the preparation of a protein peptide comprising the steps: (1) mincing tuna from which head and viscera has previously been removed, heating after adding water or heating with water steam to obtain pretreated tuna; (2) enzymolysing the pretreated tuna, deactivating the enzyme, centrifuging to obtain a supernatant; (3) concentrating the supernatant and drying to obtain the peptide powder of interest, which is the protein peptide, wherein the protease used in enzymolysis is one or more of acid protease and NEUTRASE® (neutral, zinc metallo endo-protease from Bacillus amyloliquefaciens ), and the total amount of proteases used is 0.2% to 3.2% by weight of the pretreated tuna. 2. The method according to claim 1 , wherein the step of heating after adding water or heating with steam comprises heating at 80 to 100° C. for 5 to 30 min with steam or water. 3. The method according to claim 1 , wherein the steps of enzymolysis and deactivating the enzyme comprise: mixing the pretreated tuna with protease at a temperature of 50 to 60° C. for 3.0 to 9.0 h; deactivating the enzyme at a temperature of 90 to 100° C. for 10 to 30 min after completion of the reaction. 4. The method according to claim 1 , further comprising removing impurities in the supernatant to obtain a treated supernatant before concentration. 5. The method according to claim 4 , wherein the step of removing impurities in the supernatant comprises: (1) adding activated charcoal to the supernatant in an amount of 0.3% to 2.5% by weight of the supernatant; (2) stirring at 50 to 90° C. for 0.5 to 2.0 h; (3) removing the activated charcoal by filtration. 6. The method according to claim 1 , wherein the step of concentration is conducted to achieve a solids of 30% to 45% by weight with a three-effect concentrator under a vacuum condition of 0.03 to 0.08 MPa at 60 to 80° C. 7. The method according to claim 1 , wherein the tuna is one or more of skipjack tuna, bluefin tuna, albacore tuna, and yellowfin tuna.
produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00) · CPC title
Peptides; Protein hydrolysates · CPC title
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title
from fish or other sea animals · CPC title
from fish · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.